HSA — authorised 25 April 2023
- Marketing authorisation holder: BIOGEN MA
- Status: likely_approved
HSA authorised Qalsody on 25 April 2023
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. HSA authorised it on 25 April 2023.
BIOGEN MA holds the Singaporean marketing authorisation.